FDA Drug recall D-0921-2017
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles…
- FDA Drug
- Class II
- terminated
- Published 2017-06-28
On 2017-06-28 the FDA classified a Class II recall of Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles… by Lucid Pharma, citing failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0921-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-06-01 |
| Published | 2017-06-28 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lucid Pharma |
| Distribution | US |
Product
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Reason
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Identifiers
| code_info | Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0921-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.